BioCentury – ENYO aims for Phase II, HBV, NASH trails with €40m round

https://www.biocentury.com/bc-extra/financial-news/2018-06-04/enyo-aims-phase-ii-hbv-nash-trials-%E2%82%AC40m-round

À lire dans 'Couverture médiatique'